Raymond James Financial Services Advisors Inc. Has $1.13 Million Position in Shire PLC (SHPG)
Raymond James Financial Services Advisors Inc. boosted its stake in shares of Shire PLC (NASDAQ:SHPG) by 48.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,490 shares of the biopharmaceutical company’s stock after purchasing an additional 2,117 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Shire were worth $1,130,000 at the end of the most recent reporting period.
A number of other large investors also recently added to or reduced their stakes in the stock. Abrams Capital Management L.P. acquired a new position in Shire during the 3rd quarter valued at approximately $407,338,000. Third Point LLC boosted its position in Shire by 7.5% during the 4th quarter. Third Point LLC now owns 1,719,413 shares of the biopharmaceutical company’s stock valued at $299,247,000 after purchasing an additional 119,413 shares during the period. PointState Capital LP boosted its position in Shire by 65.0% during the 3rd quarter. PointState Capital LP now owns 1,173,839 shares of the biopharmaceutical company’s stock valued at $212,782,000 after purchasing an additional 462,543 shares during the period. Pentwater Capital Management LP boosted its position in Shire by 10.1% during the 3rd quarter. Pentwater Capital Management LP now owns 996,000 shares of the biopharmaceutical company’s stock valued at $180,545,000 after purchasing an additional 91,000 shares during the period. Finally, Marshall Wace LLP boosted its position in Shire by 39.7% during the 3rd quarter. Marshall Wace LLP now owns 497,422 shares of the biopharmaceutical company’s stock valued at $90,168,000 after purchasing an additional 141,420 shares during the period. Institutional investors and hedge funds own 20.23% of the company’s stock.
Shares of SHPG stock opened at $179.20 on Thursday. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 0.36. Shire PLC has a 1 year low of $123.73 and a 1 year high of $182.47. The firm has a market cap of $54.71 billion, a price-to-earnings ratio of 11.83, a price-to-earnings-growth ratio of 1.54 and a beta of 0.87.
Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.
Read More: How is inflation measured?
Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).
Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.